Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals

Mohammad Taghiabadi; Seyed Younes Hosseini; Ali Akbar Gorzin; Seyed Alireza Taghavi; Seyed Hamid Reza Monavari; Jamal Sarvari

doi:10.5114/ceh.2019.84781

eISSN: 2449-8238
ISSN: 2392-1099

Clinical and Experimental Hepatology

Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2019
vol. 5

Send email

Copy url:

abstract:

Original paper

Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals

Mohammad Taghiabadi

¹

,

Seyed Younes Hosseini

¹

,

Ali Akbar Gorzin

¹

,

Seyed Alireza Taghavi

²

,

Seyed Hamid Reza Monavari

³

,

Jamal Sarvari

^{1, 2}

Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Clin Exp HEPATOL 2019; 5, 2: 161–168

DOI: https://doi.org/10.5114/ceh.2019.84781

Online publish date: 2019/05/08

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Taghiabadi M, Hosseini S, Gorzin A, Taghavi S, Monavari S, Sarvari J. Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals. Clinical and Experimental Hepatology. 2019;5(2):161-168. doi:10.5114/ceh.2019.84781.

APA

Taghiabadi, M., Hosseini, S., Gorzin, A., Taghavi, S., Monavari, S.,  & Sarvari, J. (2019). Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals. Clinical and Experimental Hepatology, 5(2), 161-168. https://doi.org/10.5114/ceh.2019.84781

Chicago

Taghiabadi, Mohammad, Seyed Younes Hosseini, Ali Akbar Gorzin, Seyed Alireza Taghavi, Seyed Hamid Reza Monavari,  and Jamal Sarvari. 2019. "Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals". Clinical and Experimental Hepatology 5 (2): 161-168. doi:10.5114/ceh.2019.84781.

Harvard

Taghiabadi, M., Hosseini, S., Gorzin, A., Taghavi, S., Monavari, S.,  and Sarvari, J. (2019). Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals. Clinical and Experimental Hepatology, 5(2), pp.161-168. https://doi.org/10.5114/ceh.2019.84781

MLA

Taghiabadi, Mohammad et al. "Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals." Clinical and Experimental Hepatology, vol. 5, no. 2, 2019, pp. 161-168. doi:10.5114/ceh.2019.84781.

Vancouver

Taghiabadi M, Hosseini S, Gorzin A, Taghavi S, Monavari S, Sarvari J. Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals. Clinical and Experimental Hepatology. 2019;5(2):161-168. doi:10.5114/ceh.2019.84781.

PlumX metrics:

Aim of the study
Host and viral factors can influence the clinical course of chronic hepatitis B virus (HBV) infection. Mutations in pre-S1/S2 gene regions are among the most important viral factors determining the HBV infection outcome. The aim of this study was to investigate the role of pre-S1/S2 mutations in HBV infection outcome.

Material and methods
A total of 52 samples from 26 asymptomatic carriers (ASCs) and 26 liver cirrhosis/hepatocellular carcinoma (LC/HCC) patients were enrolled. The HBV DNA genome was extracted from the sera, and pre-S1/S2 regions of the samples were amplified by nested-polymerase chain reaction, prior to being subjected to sequencing, sequence investigation and phylogenetic analysis.

Results
Certain deletions were detected mostly located at the boundary of the pre-S1 and pre-S2 regions. These deletions were detected more frequently in ASC cases than in LC/HCC patients (p < 0.007). The rate of critical point mutations, including L11Q, N37S and K38R, was significantly higher in the ASC group, whereas the A49V substitution rate was significantly higher in the LC/HCC group (p < 0.05). The phylogenetic analysis indicated that all the sequences belonged to genotype D.

Conclusions
According to the results, point mutations such as L11Q, N37S, K38R and A49V, as well as certain deletions, may be associated with HBV infection outcome, among an HBV genotype D pure population.

keywords:

Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals

Mohammad Taghiabadi 1 , Seyed Younes Hosseini 1 , Ali Akbar Gorzin 1 , Seyed Alireza Taghavi 2 , Seyed Hamid Reza Monavari 3 , Jamal Sarvari 1, 2

hepatitis B virus, genotype D, pre-S1/S2 variations, asymptomatic carrier, cirrhosis, hepatocellular carcinoma

Mohammad Taghiabadi

¹

,

Seyed Younes Hosseini

¹

,

Ali Akbar Gorzin

¹

,

Seyed Alireza Taghavi

²

,

Seyed Hamid Reza Monavari

³

,

Jamal Sarvari

^{1, 2}